Comorbidity is an independent prognostic factor in women with uterine corpus cancer: A nationwide cohort study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 4, 2014, Pages 325-334

  Noer, Mette C ^a   Sperling, Cecilie ^b   Christensen, Ib J ^c   Nielsen, Marie L S ^d   Lidegaard, Øjvind ^a   Høgdall, Claus ^a  

^a University of Copenhagen   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c FINSEN LABORATORY   (Denmark)

^d Center of Quality and Health Information East   (Denmark)

Author keywords

Charlson Comorbidity Index; comorbidity; performance status; prognostic factor; survival; Uterine corpus cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; DATA BASE; DENMARK; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; UTERUS CANCER;

CHARLSON COMORBIDITY INDEX; COMORBIDITY; PERFORMANCE STATUS; PROGNOSTIC FACTOR; SURVIVAL; UTERINE CORPUS CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SARCOMA; UTERINE NEOPLASMS;

EID: 84897110711     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12338     Document Type: Article

References (26)

1. Klint A, Tryggvadottir L, Bray F, Gislum M, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol. 2010; 49: 632-43.
2. Sorosky JI,. Endometrial cancer. Obstet Gynecol. 2008; 111: 436-47.
3. Linkov F, Taioli E,. Factors influencing endometrial cancer mortality: the Western Pennsylvania Registry. Future Oncol. 2008; 4: 857-65.
4. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr,. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004; 291: 2441-7.
5. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004; 22: 3099-103.
6. Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol. 2010; 171: 892-902.
7. Fleming ND, Lentz SE, Cass I, Li AJ, Karlan BY, Walsh CS,. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol. 2011; 120: 189-92.
8. Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21: 753-60.
9. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC,. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012; 126: 176-9.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-83.
11. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM,. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003; 56: 221-9.
12. Needham DM, Scales DC, Laupacis A, Pronovost PJ,. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005; 20: 12-9.
13. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5: 649-55.
14. Boll D, Verhoeven RH, van der Aa MA, Lybeert ML, Coebergh JW, Janssen-Heijnen ML,. Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008. Eur J Cancer. 2011; 47: 1504-10.
15. Kodama J, Seki N, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y,. Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynaecol Obstet. 2005; 91: 151-6.
16. Kwon JS, Carey MS, Cook EF, Qiu F, Paszat L,. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer. 2007; 17: 433-40.
17. Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Khunnarong J, Tanvanich S, Katanyu K, et al. Endometrial cancer in Thai women: clinico-pathological presentation and survival. Asian Pac J Cancer Prev. 2010; 11: 1267-72.
18. Truong PT, Kader HA, Lacy B, Lesperance M, MacNeil MV, Berthelet E, et al. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer. Am J Clin Oncol. 2005; 28: 157-64.
19. Wang JL, Wang ZQ, Wei LH,. Primary clinical analysis of medical disorders in Chinese women with endometrial carcinoma. Int J Gynecol Cancer. 2004; 14: 502-7.
20. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L,. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998; 16: 1582-7.
21. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G,. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59: 255-63.
22. Wedding U, Rohrig B, Klippstein A, Pientka L, Hoffken K,. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol. 2007; 133: 945-50.
23. Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G,. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol. 2007; 25: 1858-69.
24. Byrd LM, Swindell R, Webber-Rookes D, Hannon R, Hunter RD, Livsey J, et al. Endometrial adenocarcinoma: an analysis of treatment and outcome. Oncol Rep. 2008; 20: 1221-8.
25. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW,. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005; 55: 231-40.
26. Lee L, Cheung WY, Atkinson E, Krzyzanowska MK,. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2011; 29: 106-17.